Building a Compliance Training Program

Building a Compliance Training Program

Building a Compliance Training Program An Interview With Daniel Simon This year Q1’s Life Science Ethics & Compliance Training Conference is taking place in June in Chicago. Join us to hear from industry experts, including Daniel Simon from STERIS Corporation....
Session Preview: Data Analytics for Portfolio Strategy

Session Preview: Data Analytics for Portfolio Strategy

Session Preview: Data Analytics for Portfolio Strategy An Interview With Matthew Kokkonen Matthew Kokkonen of CSL Behring is one of many distinguished speakers featured at Q1’s 2nd Annual Pharmaceutical Portfolio Strategy & Management Conference taking place this...
Data Integrity for Automation Engineers

Data Integrity for Automation Engineers

Data Integrity for Automation Engineers An Interview With Frederick Johnson Frederick Johnson of Genentech, Inc. is one of many experts presenting at Q1’s Life Sciences Manufacturing Automation Optimization Conference this April. His co-presentation, “Digitizing...
Patient Reported Outcomes’ Influence on Pre-Launch Activities

Patient Reported Outcomes’ Influence on Pre-Launch Activities

Patient Reported Outcomes’ Influence on Prelaunch Activities An Interview With Ann Leon Q1’s 4th Annual Pharma & Biotech Medical Affairs Pre-Launch Strategies Conference features an array of payer, legal and industry perspectives, including Ann Leon of CSL...

Mapping KOL Relationships

Mapping KOL Relationships Session Preview with Daniel Snyder Q1’s 4th Annual Pharma & Biotech Medical Affairs Pre-Launch Strategies Conference taking place on April 29-30 features a mix of industry perspectives from experts, including Daniel Snyder of Revance...
FDA Regulatory Issues and Solutions

FDA Regulatory Issues and Solutions

FDA Regulatory Issues and Solutions Speaker Interview with Jeff Gibbs Jeff Gibbs from Hyman, Phelps & McNamara will be participating in the panel “Optimizing Primary Mode of Action Determination & Process to Appeal FDA Decisions” at Q1’s Combination Product...